Clinical trials
Aged clinical trials
Below are recruiting aged clinical trials, each written for real people, not researchers. We’re tracking 1,302 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07231705Recruiting
Plant-based formula for growth and tolerance in toddlers
This study tests how well toddlers (12-17 months old) tolerate and grow on a plant-based formula. It compares this new formula to standard ones for children who get most of their calories from formula.
Columbus, OhioAges 1 year–1.4 years - NCT06952452RecruitingPhase 3
Testing genes to improve AMD treatment
This trial studies how genes affect response to anti-VEGF injections for a common form of age-related vision loss (wet AMD). It aims to tailor treatment to each patient.
San Cristóbal de La Laguna, Santa Cruz De TenerifeAges 50 years+ - NCT07185841RecruitingPhase 1/Phase 2
Oral tablets for wet macular degeneration
This trial tests an experimental oral tablet for people with wet age-related macular degeneration. It may offer a new way to treat the condition without frequent eye injections.
BeijingAges 50–85 - NCT07486661Recruiting
Preventing frailty in people with HIV aged 65-75
This study aims to help people with HIV between the ages of 65 and 75 stay healthy and avoid becoming frail as they age. It tests a program to prevent frailty and see if it works.
BrusselsAges 65–74 - NCT06912984Recruiting
How exercise affects blood vessels as we age
This study looks at how exercise changes blood vessels differently in older women and men. You'll be randomly assigned to either an exercise program or a no-exercise control group for a few months, and researchers will measure your blood vessel health before and after.
Aurora, ColoradoAges 18 years+ - NCT07547228RecruitingPhase 1/Phase 2
PRL3-zumab for advanced age-related macular degeneration
This study tests a new injectable medicine called PRL3-zumab for patients with advanced wet macular degeneration (nAMD) whose condition hasn't improved enough with standard treatments. The goal is to see if this new approach can help preserve or improve vision in people who have already tried at least two other eye injections.
SingaporeAges 18 years+ - NCT06697288Recruiting
Sunscreen vs. usual routine for signs of aging
This study tests whether a specific sunscreen can reduce signs of skin aging on the face more than your normal routine. If you have moderate to advanced signs of aging and want to see if a new sunscreen can help, this might be for you.
Rio de JaneiroAges 30–60 - NCT07726459Recruiting
Balance and core stability in young football players
This study tests balance, core strength, and body awareness in amateur football players aged 13-19. It aims to see how these skills differ across age groups.
IstanbulAges 13–19 - NCT06506422RecruitingPhase 2/Phase 3
How empagliflozin may help aging arteries
This study tests if a diabetes medication, empagliflozin, can reduce age-related stiffening of arteries in people without diabetes. If you are between 60 and 80 and have stiff arteries, this trial could help improve your vascular health.
Columbia, MissouriAges 60–80 - NCT07676435RecruitingPhase 2
Fisetin trial for healthy lung aging
This study tests whether a natural supplement called fisetin can help slow lung decline in older adults who are either lifelong nonsmokers or long-term smokers. You would take fisetin or a placebo for a period and be monitored regularly.
Los Angeles, CaliforniaAges 60 years+ - NCT06351605Recruiting
Light therapy study for dry age-related macular degeneration
This study tests a light-based treatment (photobiomodulation) for dry AMD, using the Valeda Light Delivery System. It may help improve vision and eye health over time.
OsloAges Any age - NCT07221643Recruiting
Carotenoids, skin health and immune aging study
This study looks at how natural compounds in the skin called carotenoids relate to immune changes as we age. It compares younger and older healthy adults to understand aging better.
Redwood City, CaliforniaAges 18 years+ - NCT07309562RecruitingPhase 3
Growth hormone trial for short children born small
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
BeijingAges 2–11 - NCT06128915RecruitingPhase 4
Study of age and immune response to pneumococcal vaccine
This study is looking at how age affects the immune system's response to a pneumococcal vaccine. Researchers want to compare younger and older adults to see if immune cells change with age.
Buffalo, New YorkAges 21 years+ - NCT06123182Recruiting
Guided future thinking for exercise and brain health
This study tests whether a technique called 'guided episodic future thinking' (imagining positive future events) can help you stick with a physical activity program and support healthy brain aging. You'll be asked to exercise on a stepper machine and have MRI scans and blood draws.
Kansas City, KansasAges 45–65 - NCT07623785Recruiting
Beef and Brain Health in Older Adults
This study looks at whether eating lean beef and dairy products daily affects brain health markers in people 65 and older. Researchers will track blood, urine, and other samples to see if beef consumption influences how your brain functions at the molecular level.
Brookings, South DakotaAges 65 years+ - NCT07423429Recruiting
Switching to Aflibercept 8 mg for wet AMD
This trial tests if switching to a higher dose of aflibercept (Eylea) can help people with wet age-related macular degeneration (AMD) who need frequent eye injections. If you've been on other anti-VEGF injections for over a year and still need them more often than every 12 weeks, this study might offer a new option.
Nantes, NantesAges 18 years+ - NCT07214246Recruiting
Follicular fluid microRNAs in egg health and aging
This study looks at tiny molecules in the fluid around your eggs that may explain how age affects fertility. By joining, you help scientists understand egg health and may get insights from your own IVF treatment.
Orlando, FloridaAges 18 years+ - NCT07630649RecruitingPhase 2
Gene therapy for wet age-related macular degeneration in second eye
This study tests a one-time gene therapy injection (ixoberogene soroparvovec) in the second eye of people with wet age-related macular degeneration who have already responded well to anti-VEGF injections. The goal is to see if this gene therapy can help preserve or improve vision in that eye.
Phoenix, ArizonaAges 50 years+ - NCT07414680Recruiting
Healthy aging study for adults 40+ in Taiwan
This study looks at how to help people age healthily. It is for adults 40 and older who are connected to Chang Gung Memorial Hospital in Taiwan. You will provide health information and may have some tests to track your well-being over time.
TaipeiAges 40 years+ - NCT07392801Recruiting
Study on AGE accumulation in long-term parenteral nutrition patients
This study looks at how certain compounds called AGEs build up in the body of people who rely on long-term parenteral nutrition (nutrition given through a vein). It aims to understand whether this affects health and to find better ways to monitor patients.
BordeauxAges Any age - NCT07482657RecruitingPhase 2
Zelicapavir for RSV in infants and toddlers
This trial tests a new medicine called Zelicapavir for babies and young children (28 days to 3 years old) who have respiratory syncytial virus (RSV) infection. The medicine aims to help them recover faster and with fewer complications.
BangkokAges 4 weeks–3 years - NCT07707297Recruiting
Study of Navarre's Centenarians (born 1926-1927)
This study is for people aged 100 and older in Navarre, Spain. It aims to learn more about what contributes to a long and healthy life.
Pamplona, NavarreAges 100 years+ - NCT06507189Recruiting
How exercise affects older adults: a study
This study looks at how different older adults respond to exercise. It will help researchers understand why some people benefit more than others. You will be asked to do supervised exercise sessions and tests over about 6 months.
Pensacola, FloridaAges 60 years+
Hear when a new Aged trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for aged?
- Yes. Clin2 currently lists 1,302 recruiting aged studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a aged trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a aged trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.